Mounjaro KwikPen 15 mg contains tirzepatide, a once-weekly injectable medicine used to improve blood sugar control in adults with type 2 diabetes. It works by activating GIP and GLP-1 receptors to enhance insulin secretion and reduce appetite.
| Manufacturer | Eli Lilly and Company |
| Generic Name | Tirzepatide |
| Strength | 15mg |
| Package size | 1 pre-filled 2.4 ml pen |
| Used for | Type 2 diabetes and weight control |
Mounjaro KwikPen 10 mg contains tirzepatide, a once-weekly injectable medication used to improve blood sugar control in adults with type 2 diabetes. It works through dual GIP and GLP-1 receptor activation to enhance insulin secretion and reduce appetite.
| Manufacturer | Eli Lilly and Company |
| Generic Name | Tirzepatide |
| Strength | 10mg |
| Package size | 1 pre-filled 2.4 ml pen |
| Used for | Type 2 diabetes and weight control |
Mounjaro KwikPen 7.5 mg contains tirzepatide, a once-weekly injectable medicine used to improve blood sugar control in adults with type 2 diabetes. It works by activating both GIP and GLP-1 receptors to enhance insulin secretion and help reduce appetite.
| Manufacturer | Eli Lilly and Company |
| Generic Name | Tirzepatide |
| Strength | 7.5mg |
| Package size | 1 pre-filled 2.4 ml pen |
| Used for | Type 2 diabetes and weight control |
Mounjaro KwikPen 5 mg contains tirzepatide, a once-weekly injectable medicine used to improve blood sugar control in adults with type 2 diabetes. It works by activating GIP and GLP-1 receptors to enhance insulin release and reduce appetite.
| Manufacturer | Eli Lilly and Company |
| Generic Name | Tirzepatide |
| Strength | 5mg |
| Package size | 1 pre-filled 2.4 ml pen |
| Used for | Type 2 diabetes and weight control |
Mounjaro KwikPen 2.5 mg contains tirzepatide, a once-weekly injectable medicine commonly used as a starting dose to improve blood sugar control in adults with type 2 diabetes. It works by activating GIP and GLP-1 receptors to support insulin secretion and appetite control.
| Manufacturer | Eli Lilly and Company |
| Generic Name | Tirzepatide |
| Strength | 2.5mg |
| Package size | 1 pre-filled 2.4 ml pen |
| Used for | Type 2 diabetes and weight control |
Forxiga contains Dapagliflozin 10 mg, used to manage type 2 diabetes by helping lower blood sugar levels and supporting kidney and heart health.
| Manufacturer | AstraZeneca |
| Generic Name | Dapagliflozin |
| Strength | 10mg |
| Package size | 98 Tablets |
| Used for | Type 2 diabetes |
Bilypsa contains Saroglitazar 4 mg, used to manage high blood sugar and lipid levels in patients with type 2 diabetes and dyslipidemia.
| Manufacturer | Zydus |
| Generic Name | Saroglitazar |
| Strength | 4mg |
| Package size | 45 Tablets |
| Used for | Type 2 diabetes and dyslipidemia |
